Evosep ApS: Financial statements 2023
CVR: 37510068
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Evosep ApS (CVR 37510068) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 60,355,000 and a net result of DKK 19,777,000 compared with DKK -79,619,456 the year before. That is an increase of 12.8% compared with the year before. Equity in the 2023 report amounted to DKK 252,714,000. The solvency ratio was 91.8%. The company had 42 employees in the financial year.
- Gross Profit
- DKK 60,355,000
- Profit/Loss
- DKK 19,777,000
- Equity
- DKK 252,714,000
- Total Assets
- DKK 275,300,000
- Employees
- 42
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 60.4 mio. | 19.8 mio. | 252.7 mio. | 42 |
| 2022 | - | 53.5 mio. | -79.6 mio. | -34.4 mio. | 20 |
| 2021 | - | 36.9 mio. | 16.7 mio. | 45.2 mio. | 20 |
| 2020 | - | 21.6 mio. | 6.2 mio. | 28.5 mio. | 15 |
| 2019 | - | 9 mio. | -141 t. | 22.4 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of October 2, 2023, Morten Bern is registered as adm. dir. of Evosep ApS.
As of October 2, 2023, Christian Ravnsborg has stepped down as adm. dir. of Evosep ApS.
Evosep ApS has published its annual report for 2022. Gross profit came to DKK 53,509,833, and the net result was DKK -79,619,456.
As of January 3, 2023, Ole Vorm has joined the board of directors of Evosep ApS.
As of January 3, 2023, Stephen Neil van Helden has joined the board of directors of Evosep ApS.
As of January 2, 2023, Ole Vorm has left the board of directors of Evosep ApS.
About Evosep ApS
Evosep ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Omics Ready Biosystems ApS. The management consists of Morten Bern. The board consists of Stefan Karl Dieter Wolf (chair), Jens Bornhøft Christensen and Morten Bern. The company is owned by Paradigm BidCo ApS. The company has 16 employees (2018). In 2025, the company reported a gross profit of DKK 72,369,000 and a net result of DKK -221,637,000 compared with DKK -2,613,000 the year before. Equity in the 2025 report amounted to DKK 154,548,000.